Skip to main content

Vaccine Update Newsletter: January 2024

Vaccine Update Newsletter: January 2024

News

In the Journals: Nirsevimab

Find out about the results of a prospective, placebo-controlled trial in 8,058 healthy infants that served as the basis for licensure of nirsevimab.

Jump back to top